News search

    E.g., 26/11/2024
    E.g., 26/11/2024
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    Photo
    Research
    8 Jan 2019
    Circulation: Expression of a molecule in blood cells predicts atherosclerosis risk

    The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors
    Foto
    Research
    19 Nov 2018
    The CNIC Conference addresses the emerging concepts of cardiovascular biology

    The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

    De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
    Research
    3 Apr 2018
    Science Translational Medicine: CNIC scientists identify a promising target for the treatment of heart failure

    The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
    Research
    3 Apr 2018
    Seventh call for proposals to access the ReDIB Scientific and Technical Singular Infrastructures (STSI)

    ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián
    De izquierda a derecha, Emilio Camafeita, Vanessa Núñez, Cristina Clemente, Alicia G. Arroyo, Laura Alonso-Herranz, Cristina Rius y Vicente Andrés.
    Research
    2 Mar 2018
    Nature Communications: Blocking a protein could improve the effectiveness of intravascular cellular 'policing'

    The study, published in Nature Communications, shows that blockade of the protease MT4-MMP increases the activity of blood-patrolling monocytes in the circulation.
    Foto de grupo
    Research
    14 Nov 2017
    JACC: Five health indicators are enough to predict cardiovascular risk in healthy people

    The Fuster-BEWAT score evaluates five health indicators: blood pressure, physical activity, body-mass index (BMI), fruit and vegetable intake, and smoking status
    De izda. a dcha.: Iciar Areilza, Gonzalo Pizarro y Borja Ibáñez del CNIC, junto a Jesús Sánchez Martos, Consuelo Serrano, José de la Sota y Sara Alfonso, de la Fundación madri+d
    About the CNIC
    3 Nov 2017
    The Madri+d Foundation visits the CNIC

    The director of the Madri+d Knowledge Foundation, Jesus Sánchez Martos, visits the Carlos III National Center for Cardiovascular Research (CNIC) to learn first-hand about its main lines of research and explore new ways of collaboration
    La Dra. Guadalupe Sabio en su laboratorio.
    About the CNIC
    25 Oct 2017
    Dr. Guadalupe Sabio joins the EMBO’s network of young researchers

    Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer.